Loading...

Paul Mischel

Title(s)Professor, Pathology
SchoolHealth Sciences
Address9500 Gilman Drive #0753
La Jolla CA 92093
Phone858-534-6080
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    The role of mTORC2 in reprogramming cancer cell metabolism
    NIH/NINDS R01NS073831Jun 15, 2011 - May 31, 2021
    Role: Principal Investigator
    Glioblastoma - Molecular Analysis for Clinical Trials
    NIH/NINDS R01NS050151Dec 1, 2004 - Nov 30, 2009
    Role: Principal Investigator
    Trk receptor mediated apoptosis of medulloblastoma cells
    NIH/NINDS K08NS043147Sep 20, 2001 - Aug 31, 2006
    Role: Principal Investigator
    TEMPORALLY DEPENDENT MECHANISMS OF NEUROTROPHIN 3 ACTION
    NIH/NINDS F32NS010301Jul 1, 1997
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. What Is Extrachromosomal Circular DNA and What Does It Do? Clin Chem. 2020 Jun 01; 66(6):754-759. Chiu RWK, Dutta A, Hensson AG, Lo YMD, Mischel P, Regenberg B. PMID: 32470125.
      View in: PubMed   Mentions:    Fields:    
    2. Dual Regulation of Histone Methylation by mTOR Complexes Controls Glioblastoma Tumor Cell Growth via EZH2 and SAM. Mol Cancer Res. 2020 May 04. Harachi M, Masui K, Honda H, Muragaki Y, Kawamata T, Cavenee WK, Mischel PS, Shibata N. PMID: 32366675.
      View in: PubMed   Mentions:    Fields:    
    3. Author Correction: Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells. Nat Commun. 2020 Apr 20; 11(1):1958. Koga T, Chaim IA, Benitez JA, Markmiller S, Parisian AD, Hevner RF, Turner KM, Hessenauer FM, D'Antonio M, Nguyen ND, Saberi S, Ma J, Miki S, Boyer AD, Ravits J, Frazer KA, Bafna V, Chen CC, Mischel PS, Yeo GW, Furnari FB. PMID: 32312984.
      View in: PubMed   Mentions:    Fields:    
    4. Extrachromosomal DNA-relieving heredity constraints, accelerating tumour evolution. Ann Oncol. 2020 Jul; 31(7):884-893. Bailey C, Shoura MJ, Mischel PS, Swanton C. PMID: 32275948.
      View in: PubMed   Mentions:    Fields:    
    5. mTOR complex 2 is an integrator of cancer metabolism and epigenetics. Cancer Lett. 2020 May 28; 478:1-7. Masui K, Harachi M, Cavenee WK, Mischel PS, Shibata N. PMID: 32145344.
      View in: PubMed   Mentions:    Fields:    
    6. Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells. Nat Commun. 2020 Jan 28; 11(1):550. Koga T, Chaim IA, Benitez JA, Markmiller S, Parisian AD, Hevner RF, Turner KM, Hessenauer FM, D'Antonio M, Nguyen ND, Saberi S, Ma J, Miki S, Boyer AD, Ravits J, Frazer KA, Bafna V, Chen CC, Mischel PS, Yeo GW, Furnari FB. PMID: 31992716.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    7. Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets. Nat Rev Cancer. 2020 01; 20(1):57-70. Bi J, Chowdhry S, Wu S, Zhang W, Masui K, Mischel PS. PMID: 31806884.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    8. Circular ecDNA promotes accessible chromatin and high oncogene expression. Nature. 2019 11; 575(7784):699-703. Wu S, Turner KM, Nguyen N, Raviram R, Erb M, Santini J, Luebeck J, Rajkumar U, Diao Y, Li B, Zhang W, Jameson N, Corces MR, Granja JM, Chen X, Coruh C, Abnousi A, Houston J, Ye Z, Hu R, Yu M, Kim H, Law JA, Verhaak RGW, Hu M, Furnari FB, Chang HY, Ren B, Bafna V, Mischel PS. PMID: 31748743.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    9. mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma. J Biol Chem. 2019 12 20; 294(51):19740-19751. Masui K, Harachi M, Ikegami S, Yang H, Onizuka H, Yong WH, Cloughesy TF, Muragaki Y, Kawamata T, Arai N, Komori T, Cavenee WK, Mischel PS, Shibata N. PMID: 31712311.
      View in: PubMed   Mentions:    Fields:    
    10. EcSeg: Semantic Segmentation of Metaphase Images Containing Extrachromosomal DNA. iScience. 2019 Nov 22; 21:428-435. Rajkumar U, Turner K, Luebeck J, Deshpande V, Chandraker M, Mischel P, Bafna V. PMID: 31706138.
      View in: PubMed   Mentions:
    11. Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations. Mol Cancer Ther. 2020 02; 19(2):602-613. Park PH, Yamamoto TM, Li H, Alcivar AL, Xia B, Wang Y, Bernhardy AJ, Turner KM, Kossenkov AV, Watson ZL, Behbakht K, Casadei S, Swisher EM, Mischel PS, Johnson N, Bitler BG. PMID: 31575654.
      View in: PubMed   Mentions:    Fields:    
    12. Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells. Sci Transl Med. 2019 08 07; 11(504). Wang X, Yang K, Wu Q, Kim LJY, Morton AR, Gimple RC, Prager BC, Shi Y, Zhou W, Bhargava S, Zhu Z, Jiang L, Tao W, Qiu Z, Zhao L, Zhang G, Li X, Agnihotri S, Mischel PS, Mack SC, Bao S, Rich JN. PMID: 31391321.
      View in: PubMed   Mentions:    Fields:    
    13. Acyl-CoA-Binding Protein Fuels Gliomagenesis. Cell Metab. 2019 08 06; 30(2):229-230. Bi J, Mischel PS. PMID: 31390546.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Nat Cell Biol. 2019 08; 21(8):1003-1014. Kofuji S, Hirayama A, Eberhardt AO, Kawaguchi R, Sugiura Y, Sampetrean O, Ikeda Y, Warren M, Sakamoto N, Kitahara S, Yoshino H, Yamashita D, Sumita K, Wolfe K, Lange L, Ikeda S, Shimada H, Minami N, Malhotra A, Morioka S, Ban Y, Asano M, Flanary VL, Ramkissoon A, Chow LML, Kiyokawa J, Mashimo T, Lucey G, Mareninov S, Ozawa T, Onishi N, Okumura K, Terakawa J, Daikoku T, Wise-Draper T, Majd N, Kofuji K, Sasaki M, Mori M, Kanemura Y, Smith EP, Anastasiou D, Wakimoto H, Holland EC, Yong WH, Horbinski C, Nakano I, DeBerardinis RJ, Bachoo RM, Mischel PS, Yasui W, Suematsu M, Saya H, Soga T, Grummt I, Bierhoff H, Sasaki AT. PMID: 31371825.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    15. Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling. Cell Metab. 2019 09 03; 30(3):525-538.e8. Bi J, Ichu TA, Zanca C, Yang H, Zhang W, Gu Y, Chowdhry S, Reed A, Ikegami S, Turner KM, Zhang W, Villa GR, Wu S, Quehenberger O, Yong WH, Kornblum HI, Rich JN, Cloughesy TF, Cavenee WK, Furnari FB, Cravatt BF, Mischel PS. PMID: 31303424.
      View in: PubMed   Mentions: 1     Fields:    
    16. Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling. Cancer Discov. 2019 09; 9(9):1248-1267. Gimple RC, Kidwell RL, Kim LJY, Sun T, Gromovsky AD, Wu Q, Wolf M, Lv D, Bhargava S, Jiang L, Prager BC, Wang X, Ye Q, Zhu Z, Zhang G, Dong Z, Zhao L, Lee D, Bi J, Sloan AE, Mischel PS, Brown JM, Cang H, Huan T, Mack SC, Xie Q, Rich JN. PMID: 31201181.
      View in: PubMed   Mentions: 1     Fields:    
    17. Extrachromosomal oncogene amplification in tumour pathogenesis and evolution. Nat Rev Cancer. 2019 05; 19(5):283-288. Verhaak RGW, Bafna V, Mischel PS. PMID: 30872802.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    18. NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling. Nature. 2019 05; 569(7757):570-575. Chowdhry S, Zanca C, Rajkumar U, Koga T, Diao Y, Raviram R, Liu F, Turner K, Yang H, Brunk E, Bi J, Furnari F, Bafna V, Ren B, Mischel PS. PMID: 31019297.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    19. A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer. Proc Natl Acad Sci U S A. 2019 03 26; 116(13):6435-6440. Lucki NC, Villa GR, Vergani N, Bollong MJ, Beyer BA, Lee JW, Anglin JL, Spangenberg SH, Chin EN, Sharma A, Johnson K, Sander PN, Gordon P, Skirboll SL, Wurdak H, Schultz PG, Mischel PS, Lairson LL. PMID: 30846550.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    20. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat Commun. 2019 01 23; 10(1):392. Deshpande V, Luebeck J, Nguyen ND, Bakhtiari M, Turner KM, Schwab R, Carter H, Mischel PS, Bafna V. PMID: 30674876.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    21. Metabolic reprogramming in the pathogenesis of glioma: Update. Neuropathology. 2019 Feb; 39(1):3-13. Masui K, Onizuka H, Cavenee WK, Mischel PS, Shibata N. PMID: 30609184.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    22. mTOR Complexes as a Nutrient Sensor for Driving Cancer Progression. Int J Mol Sci. 2018 Oct 21; 19(10). Harachi M, Masui K, Okamura Y, Tsukui R, Mischel PS, Shibata N. PMID: 30347859.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    23. Breast cancer treatment and its effects on aging. J Geriatr Oncol. 2019 03; 10(2):346-355. Chang L, Weiner LS, Hartman SJ, Horvath S, Jeste D, Mischel PS, Kado DM. PMID: 30078714.
      View in: PubMed   Mentions: 2     Fields:    
    24. Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response. Cancers (Basel). 2018 Jul 25; 10(8). Donoghue JF, Kerr LT, Alexander NW, Greenall SA, Longano AB, Gottardo NG, Wang R, Tabar V, Adams TE, Mischel PS, Johns TG. PMID: 30044378.
      View in: PubMed   Mentions:
    25. Targeting cancer's metabolic co-dependencies: A landscape shaped by genotype and tissue context. Biochim Biophys Acta Rev Cancer. 2018 08; 1870(1):76-87. Bi J, Wu S, Zhang W, Mischel PS. PMID: 29775654.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. ViFi: accurate detection of viral integration and mRNA fusion reveals indiscriminate and unregulated transcription in proximal genomic regions in cervical cancer. Nucleic Acids Res. 2018 04 20; 46(7):3309-3325. Nguyen ND, Deshpande V, Luebeck J, Mischel PS, Bafna V. PMID: 29579309.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    27. Molecular and Genetic Determinants of Glioma Cell Invasion. Int J Mol Sci. 2017 Dec 04; 18(12). Masui K, Kato Y, Sawada T, Mischel PS, Shibata N. PMID: 29207533.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. Cancer Cell. 2017 Dec 11; 32(6):856-868.e5. Cosset É, Ilmjärv S, Dutoit V, Elliott K, von Schalscha T, Camargo MF, Reiss A, Moroishi T, Seguin L, Gomez G, Moo JS, Preynat-Seauve O, Krause KH, Chneiweiss H, Sarkaria JN, Guan KL, Dietrich PY, Weis SM, Mischel PS, Cheresh DA. PMID: 29198914.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    29. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017 Nov; 23(11):1342-1351. Mai WX, Gosa L, Daniels VW, Ta L, Tsang JE, Higgins B, Gilmore WB, Bayley NA, Harati MD, Lee JT, Yong WH, Kornblum HI, Bensinger SJ, Mischel PS, Rao PN, Clark PM, Cloughesy TF, Letai A, Nathanson DA. PMID: 29035366.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    30. Targeting epidermal growth factor receptor co-dependent signaling pathways in glioblastoma. Wiley Interdiscip Rev Syst Biol Med. 2018 01; 10(1). Liu F, Mischel PS. PMID: 28892308.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    31. mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT. Mol Cell. 2017 Jul 06; 67(1):128-138.e7. Gu Y, Albuquerque CP, Braas D, Zhang W, Villa GR, Bi J, Ikegami S, Masui K, Gini B, Yang H, Gahman TC, Shiau AK, Cloughesy TF, Christofk HR, Zhou H, Guan KL, Mischel PS. PMID: 28648777.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    32. Glioblastoma cellular cross-talk converges on NF-?B to attenuate EGFR inhibitor sensitivity. Genes Dev. 2017 06 15; 31(12):1212-1227. Zanca C, Villa GR, Benitez JA, Thorne AH, Koga T, D'Antonio M, Ikegami S, Ma J, Boyer AD, Banisadr A, Jameson NM, Parisian AD, Eliseeva OV, Barnabe GF, Liu F, Wu S, Yang H, Wykosky J, Frazer KA, Verkhusha VV, Isaguliants MG, Weiss WA, Gahman TC, Shiau AK, Chen CC, Mischel PS, Cavenee WK, Furnari FB. PMID: 28724615.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    33. Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling. NPJ Precis Oncol. 2017; 1(1):1. Liu F, Mischel PS, Cavenee WK. PMID: 29872691.
      View in: PubMed   Mentions:
    34. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature. 2017 03 02; 543(7643):122-125. Turner KM, Deshpande V, Beyter D, Koga T, Rusert J, Lee C, Li B, Arden K, Ren B, Nathanson DA, Kornblum HI, Taylor MD, Kaushal S, Cavenee WK, Wechsler-Reya R, Furnari FB, Vandenberg SR, Rao PN, Wahl GM, Bafna V, Mischel PS. PMID: 28178237.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    35. An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers. Cancer Cell. 2016 Nov 14; 30(5):683-693. Villa GR, Hulce JJ, Zanca C, Bi J, Ikegami S, Cahill GL, Gu Y, Lum KM, Masui K, Yang H, Rong X, Hong C, Turner KM, Liu F, Hon GC, Jenkins D, Martini M, Armando AM, Quehenberger O, Cloughesy TF, Furnari FB, Cavenee WK, Tontonoz P, Gahman TC, Shiau AK, Cravatt BF, Mischel PS. PMID: 27746144.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    36. mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling. Bioessays. 2016 09; 38(9):839-44. Masui K, Shibata N, Cavenee WK, Mischel PS. PMID: 27427440.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    37. Challenges in identifying cancer genes by analysis of exome sequencing data. Nat Commun. 2016 07 15; 7:12096. Hofree M, Carter H, Kreisberg JF, Bandyopadhyay S, Mischel PS, Friend S, Ideker T. PMID: 27417679.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    38. PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma. Cancer Res. 2016 08 15; 76(16):4708-19. Agnihotri S, Golbourn B, Huang X, Remke M, Younger S, Cairns RA, Chalil A, Smith CA, Krumholtz SL, Mackenzie D, Rakopoulos P, Ramaswamy V, Taccone MS, Mischel PS, Fuller GN, Hawkins C, Stanford WL, Taylor MD, Zadeh G, Rutka JT. PMID: 27325644.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    39. Cancer metabolism as a central driving force of glioma pathogenesis. Brain Tumor Pathol. 2016 Jul; 33(3):161-8. Masui K, Cavenee WK, Mischel PS. PMID: 27295313.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    40. Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma. Nat Neurosci. 2016 05 26; 19(6):765-7. Villa GR, Mischel PS. PMID: 27227363.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    41. Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma. Cancer Cell. 2016 Apr 11; 29(4):563-573. Wei W, Shin YS, Xue M, Matsutani T, Masui K, Yang H, Ikegami S, Gu Y, Herrmann K, Johnson D, Ding X, Hwang K, Kim J, Zhou J, Su Y, Li X, Bonetti B, Chopra R, James CD, Cavenee WK, Cloughesy TF, Mischel PS, Heath JR, Gini B. PMID: 27070703.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    42. Molecular classification of gliomas. Handb Clin Neurol. 2016; 134:97-120. Masui K, Mischel PS, Reifenberger G. PMID: 26948350.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    43. Single-cell analysis tools for drug discovery and development. Nat Rev Drug Discov. 2016 Mar; 15(3):204-16. Heath JR, Ribas A, Mischel PS. PMID: 26669673.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimals
    44. AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models. J Neurooncol. 2016 Jan; 126(2):253-64. Chang E, Pohling C, Natarajan A, Witney TH, Kaur J, Xu L, Gowrishankar G, D'Souza AL, Murty S, Schick S, Chen L, Wu N, Khaw P, Mischel P, Abbasi T, Usmani S, Mallick P, Gambhir SS. PMID: 26650066.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    45. mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment. Brain Pathol. 2015 Nov; 25(6):755-9. Masui K, Cavenee WK, Mischel PS. PMID: 26526943.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    46. Metabolic Reprogramming in Brain Cancer: A Coordinated Effort. Brain Pathol. 2015 Nov; 25(6):753-4. Venneti S, Mischel PS. PMID: 26526942.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling. Mol Cell. 2015 Oct 15; 60(2):307-18. Liu F, Hon GC, Villa GR, Turner KM, Ikegami S, Yang H, Ye Z, Li B, Kuan S, Lee AY, Zanca C, Wei B, Lucey G, Jenkins D, Zhang W, Barr CL, Furnari FB, Cloughesy TF, Yong WH, Gahman TC, Shiau AK, Cavenee WK, Ren B, Mischel PS. PMID: 26455392.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    48. Shared Intelligence: A Patient-Derived, Deeply Characterized Glioblastoma Cell Line Resource. EBioMedicine. 2015 Oct; 2(10):1274-5. Villa GR, Mischel PS. PMID: 26629504.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    49. A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma. Cancer. 2015 Oct 01; 121(19):3481-90. Bendell JC, Kelley RK, Shih KC, Grabowsky JA, Bergsland E, Jones S, Martin T, Infante JR, Mischel PS, Matsutani T, Xu S, Wong L, Liu Y, Wu X, Mortensen DS, Chopra R, Hege K, Munster PN. PMID: 26177599.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    50. Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance. Proc Natl Acad Sci U S A. 2015 Jul 28; 112(30):9406-11. Masui K, Tanaka K, Ikegami S, Villa GR, Yang H, Yong WH, Cloughesy TF, Yamagata K, Arai N, Cavenee WK, Mischel PS. PMID: 26170313.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    51. Significance of filamin A in mTORC2 function in glioblastoma. Mol Cancer. 2015 Jul 02; 14:127. Chantaravisoot N, Wongkongkathep P, Loo JA, Mischel PS, Tamanoi F. PMID: 26134617.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    52. Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma. Nat Rev Cancer. 2015 May; 15(5):302-10. Furnari FB, Cloughesy TF, Cavenee WK, Mischel PS. PMID: 25855404.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    53. Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. J Clin Invest. 2015 Apr; 125(4):1591-602. Tanaka K, Sasayama T, Irino Y, Takata K, Nagashima H, Satoh N, Kyotani K, Mizowaki T, Imahori T, Ejima Y, Masui K, Gini B, Yang H, Hosoda K, Sasaki R, Mischel PS, Kohmura E. PMID: 25798620.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    54. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. Proc Natl Acad Sci U S A. 2015 Jan 27; 112(4):1107-12. Chen K, Yang D, Li X, Sun B, Song F, Cao W, Brat DJ, Gao Z, Li H, Liang H, Zhao Y, Zheng H, Li M, Buckner J, Patterson SD, Ye X, Reinhard C, Bhathena A, Joshi D, Mischel PS, Croce CM, Wang YM, Raghavakaimal S, Li H, Lu X, Pan Y, Chang H, Ba S, Luo L, Cavenee WK, Zhang W, Hao X. PMID: 25583476.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    55. Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance. Cancer Biol Med. 2014 Dec; 11(4):255-63. Wu SH, Bi JF, Cloughesy T, Cavenee WK, Mischel PS. PMID: 25610711.
      View in: PubMed   Mentions:
    56. A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma. Cancer Res. 2015 Jan 15; 75(2):394-404. Wykosky J, Hu J, Gomez GG, Taylor T, Villa GR, Pizzo D, VandenBerg SR, Thorne AH, Chen CC, Mischel PS, Gonias SL, Cavenee WK, Furnari FB. PMID: 25432173.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    57. Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas. Clin Cancer Res. 2014 Nov 15; 20(22):5808-22. Li S, Chowdhury R, Liu F, Chou AP, Li T, Mody RR, Lou JJ, Chen W, Reiss J, Soto H, Prins R, Liau LM, Mischel PS, Nghiemphu PL, Yong WH, Cloughesy TF, Lai A. PMID: 25224277.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    58. Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group. Neuro Oncol. 2015 Feb; 17(2):180-8. Alexander BM, Galanis E, Yung WK, Ballman KV, Boyett JM, Cloughesy TF, Degroot JF, Huse JT, Mann B, Mason W, Mellinghoff IK, Mikkelsen T, Mischel PS, O'Neill BP, Prados MD, Sarkaria JN, Tawab-Amiri A, Trippa L, Ye X, Ligon KL, Berry DA, Wen PY. PMID: 25165194.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    59. Greater than the sum of its parts: single-nucleus sequencing identifies convergent evolution of independent EGFR mutants in GBM. Cancer Discov. 2014 Aug; 4(8):876-8. Gini B, Mischel PS. PMID: 25092745.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    60. Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways. Neuro Oncol. 2014 Jul; 16(7):933-45. Bernhart E, Damm S, Heffeter P, Wintersperger A, Asslaber M, Frank S, Hammer A, Strohmaier H, DeVaney T, Mrfka M, Eder H, Windpassinger C, Ireson CR, Mischel PS, Berger W, Sattler W. PMID: 24463355.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    61. mTORC2 in the center of cancer metabolic reprogramming. Trends Endocrinol Metab. 2014 Jul; 25(7):364-73. Masui K, Cavenee WK, Mischel PS. PMID: 24856037.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    62. Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma. J Biol Chem. 2014 May 16; 289(20):13974-85. Qin Y, Fu M, Takahashi M, Iwanami A, Kuga D, Rao RG, Sudhakar D, Huang T, Kiyohara M, Torres K, Dillard C, Inagaki A, Kasahara N, Goodglick L, Braun J, Mischel PS, Gordon LK, Wadehra M. PMID: 24644285.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    63. Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients. BMC Cancer. 2014 Mar 05; 14:152. Lagadec C, Vlashi E, Bhuta S, Lai C, Mischel P, Werner M, Henke M, Pajonk F. PMID: 24593279.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    64. mTORC2 dictates Warburg effect and drug resistance. Cell Cycle. 2014; 13(7):1053-4. Masui K, Cavenee WK, Mischel PS. PMID: 24583874.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    65. Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des. 2014; 20(15):2619-26. Guo D, Bell EH, Mischel P, Chakravarti A. PMID: 23859617.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCells
    66. Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science. 2014 Jan 03; 343(6166):72-6. Nathanson DA, Gini B, Mottahedeh J, Visnyei K, Koga T, Gomez G, Eskin A, Hwang K, Wang J, Masui K, Paucar A, Yang H, Ohashi M, Zhu S, Wykosky J, Reed R, Nelson SF, Cloughesy TF, James CD, Rao PN, Kornblum HI, Heath JR, Cavenee WK, Furnari FB, Mischel PS. PMID: 24310612.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansAnimalsCells
    67. Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence. PLoS One. 2013; 8(11):e80397. Ye F, Zhang Y, Liu Y, Yamada K, Tso JL, Menjivar JC, Tian JY, Yong WH, Schaue D, Mischel PS, Cloughesy TF, Nelson SF, Liau LM, McBride W, Tso CL. PMID: 24260384.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    68. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 2013 Nov 05; 18(5):726-39. Masui K, Tanaka K, Akhavan D, Babic I, Gini B, Matsutani T, Iwanami A, Liu F, Villa GR, Gu Y, Campos C, Zhu S, Yang H, Yong WH, Cloughesy TF, Mellinghoff IK, Cavenee WK, Shaw RJ, Mischel PS. PMID: 24140020.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansAnimalsCells
    69. The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas. Clin Cancer Res. 2013 Oct 15; 19(20):5722-32. Gini B, Zanca C, Guo D, Matsutani T, Masui K, Ikegami S, Yang H, Nathanson D, Villa GR, Shackelford D, Zhu S, Tanaka K, Babic I, Akhavan D, Lin K, Assuncao A, Gu Y, Bonetti B, Mortensen DS, Xu S, Raymon HK, Cavenee WK, Furnari FB, James CD, Kroemer G, Heath JR, Hege K, Chopra R, Cloughesy TF, Mischel PS. PMID: 24030701.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    70. Fast metabolic response to drug intervention through analysis on a miniaturized, highly integrated molecular imaging system. J Nucl Med. 2013 Oct; 54(10):1820-4. Wang J, Hwang K, Braas D, Dooraghi A, Nathanson D, Campbell DO, Gu Y, Sandberg T, Mischel P, Radu C, Chatziioannou AF, Phelps ME, Christofk H, Heath JR. PMID: 23978446.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    71. Glioblastoma: from molecular pathology to targeted treatment. Annu Rev Pathol. 2014; 9:1-25. Cloughesy TF, Cavenee WK, Mischel PS. PMID: 23937436.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansAnimals
    72. EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. Cell Metab. 2013 Jun 04; 17(6):1000-8. Babic I, Anderson ES, Tanaka K, Guo D, Masui K, Li B, Zhu S, Gu Y, Villa GR, Akhavan D, Nathanson D, Gini B, Mareninov S, Li R, Camacho CE, Kurdistani SK, Eskin A, Nelson SF, Yong WH, Cavenee WK, Cloughesy TF, Christofk HR, Black DL, Mischel PS. PMID: 23707073.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    73. Lyophilized brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1 year of room temperature storage. J Neurooncol. 2013 Jul; 113(3):365-73. Mareninov S, De Jesus J, Sanchez DE, Kay AB, Wilson RW, Babic I, Chen W, Telesca D, Lou JJ, Mirsadraei L, Gardner TP, Khanlou N, Vinters HV, Shafa BB, Lai A, Liau LM, Mischel PS, Cloughesy TF, Yong WH. PMID: 23640138.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    74. Arsenic reverses glioblastoma resistance to mTOR-targeted therapies. Cell Cycle. 2013 May 15; 12(10):1473-4. Iwanami A, Cloughesy TF, Cavenee WK, Mischel PS. PMID: 23624839.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    75. When is hub gene selection better than standard meta-analysis? PLoS One. 2013; 8(4):e61505. Langfelder P, Mischel PS, Horvath S. PMID: 23613865.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansAnimals
    76. On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment. Exp Cell Res. 2013 Jul 15; 319(12):1828-38. Eibinger G, Fauler G, Bernhart E, Frank S, Hammer A, Wintersperger A, Eder H, Heinemann A, Mischel PS, Malle E, Sattler W. PMID: 23541792.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    77. De-repression of PDGFRß transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients. Cancer Discov. 2013 May; 3(5):534-47. Akhavan D, Pourzia AL, Nourian AA, Williams KJ, Nathanson D, Babic I, Villa GR, Tanaka K, Nael A, Yang H, Dang J, Vinters HV, Yong WH, Flagg M, Tamanoi F, Sasayama T, James CD, Kornblum HI, Cloughesy TF, Cavenee WK, Bensinger SJ, Mischel PS. PMID: 23533263.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    78. Hypoxia induces a phase transition within a kinase signaling network in cancer cells. Proc Natl Acad Sci U S A. 2013 Apr 09; 110(15):E1352-60. Wei W, Shi Q, Remacle F, Qin L, Shackelford DB, Shin YS, Mischel PS, Levine RD, Heath JR. PMID: 23530221.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    79. A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments. Carcinogenesis. 2013 Apr; 34(4):725-38. Masui K, Gini B, Wykosky J, Zanca C, Mischel PS, Furnari FB, Cavenee WK. PMID: 23455378.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    80. PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies. Proc Natl Acad Sci U S A. 2013 Mar 12; 110(11):4339-44. Iwanami A, Gini B, Zanca C, Matsutani T, Assuncao A, Nael A, Dang J, Yang H, Zhu S, Kohyama J, Kitabayashi I, Cavenee WK, Cloughesy TF, Furnari FB, Nakamura M, Toyama Y, Okano H, Mischel PS. PMID: 23440206.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    81. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer Res. 2013 May 01; 73(9):2850-62. Williams KJ, Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG, Kidani Y, Pourzia AL, Akhavan D, Lisiero DN, Komisopoulou E, Henkin AH, Soto H, Chamberlain BT, Vergnes L, Jung ME, Torres JZ, Liau LM, Christofk HR, Prins RM, Mischel PS, Reue K, Graeber TG, Bensinger SJ. PMID: 23440422.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimalsCells
    82. A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma. PLoS Genet. 2013; 9(2):e1003253. Read RD, Fenton TR, Gomez GG, Wykosky J, Vandenberg SR, Babic I, Iwanami A, Yang H, Cavenee WK, Mischel PS, Furnari FB, Thomas JB. PMID: 23459592.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    83. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nat Genet. 2013 Mar; 45(3):253-61. Morris LG, Kaufman AM, Gong Y, Ramaswami D, Walsh LA, Turcan S, Eng S, Kannan K, Zou Y, Peng L, Banuchi VE, Paty P, Zeng Z, Vakiani E, Solit D, Singh B, Ganly I, Liau L, Cloughesy TC, Mischel PS, Mellinghoff IK, Chan TA. PMID: 23354438.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimalsCells
    84. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell. 2013 Feb 11; 23(2):143-58. Shackelford DB, Abt E, Gerken L, Vasquez DS, Seki A, Leblanc M, Wei L, Fishbein MC, Czernin J, Mischel PS, Shaw RJ. PMID: 23352126.
      View in: PubMed   Mentions: 186     Fields:    Translation:HumansAnimalsCells
    85. Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome. Neuro Oncol. 2013 Mar; 15(3):370-81. Lalezari S, Chou AP, Tran A, Solis OE, Khanlou N, Chen W, Li S, Carrillo JA, Chowdhury R, Selfridge J, Sanchez DE, Wilson RW, Zurayk M, Lalezari J, Lou JJ, Ormiston L, Ancheta K, Hanna R, Miller P, Piccioni D, Ellingson BM, Buchanan C, Mischel PS, Nghiemphu PL, Green R, Wang HJ, Pope WB, Liau LM, Elashoff RM, Cloughesy TF, Yong WH, Lai A. PMID: 23328811.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    86. Multiple functions of a glioblastoma fusion oncogene. J Clin Invest. 2013 Feb; 123(2):548-51. Babic I, Mischel PS. PMID: 23298839.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    87. Pilot study on "pericytic mimicry" and potential embryonic/stem cell properties of angiotropic melanoma cells interacting with the abluminal vascular surface. Cancer Microenviron. 2013 Apr; 6(1):19-29. Lugassy C, Wadehra M, Li X, Corselli M, Akhavan D, Binder SW, Péault B, Cochran AJ, Mischel PS, Kleinman HK, Barnhill RL. PMID: 23275074.
      View in: PubMed   Mentions:
    88. RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. Int J Radiat Oncol Biol Phys. 2013 Apr 01; 85(5):1206-11. Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG, Schultz CJ, Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M, Molinaro A, Mischel P, Dicker AP, Bredel M, Mehta M. PMID: 23182702.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    89. Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am J Neuroradiol. 2013 Mar; 34(3):533-40. Ellingson BM, Lai A, Harris RJ, Selfridge JM, Yong WH, Das K, Pope WB, Nghiemphu PL, Vinters HV, Liau LM, Mischel PS, Cloughesy TF. PMID: 22997168.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    90. Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas. J Natl Cancer Inst. 2012 Oct 03; 104(19):1458-69. Chou AP, Chowdhury R, Li S, Chen W, Kim AJ, Piccioni DE, Selfridge JM, Mody RR, Chang S, Lalezari S, Lin J, Sanchez DE, Wilson RW, Garrett MC, Harry B, Mottahedeh J, Nghiemphu PL, Kornblum HI, Mischel PS, Prins RM, Yong WH, Cloughesy T, Nelson SF, Liau LM, Lai A. PMID: 22945948.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    91. Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240. Proc Natl Acad Sci U S A. 2012 Aug 28; 109(35):14164-9. Fenton TR, Nathanson D, Ponte de Albuquerque C, Kuga D, Iwanami A, Dang J, Yang H, Tanaka K, Oba-Shinjo SM, Uno M, Inda MM, Wykosky J, Bachoo RM, James CD, DePinho RA, Vandenberg SR, Zhou H, Marie SK, Mischel PS, Cavenee WK, Furnari FB. PMID: 22891331.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    92. Discovery in context: leveraging multidimensional glioblastoma datasets to identify targetable regulatory networks. Cancer Discov. 2012 Aug; 2(8):676-8. Babic I, Mischel PS. PMID: 22886662.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    93. Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death. Mol Syst Biol. 2012 Jun 26; 8:589. Graham NA, Tahmasian M, Kohli B, Komisopoulou E, Zhu M, Vivanco I, Teitell MA, Wu H, Ribas A, Lo RS, Mellinghoff IK, Mischel PS, Graeber TG. PMID: 22735335.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    94. HOT models in flux: mitochondrial glucose oxidation fuels glioblastoma growth. Cell Metab. 2012 Jun 06; 15(6):789-90. Mischel PS. PMID: 22682216.
      View in: PubMed   Mentions: 6     Fields:    
    95. Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla. Neuro Oncol. 2012 Aug; 14(8):1050-61. Chaumeil MM, Gini B, Yang H, Iwanami A, Sukumar S, Ozawa T, Pieper RO, Mischel PS, James CD, Berger MS, Ronen SM. PMID: 22670012.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    96. Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies. Neuropathol Appl Neurobiol. 2012 Jun; 38(3):271-91. Masui K, Cloughesy TF, Mischel PS. PMID: 22098029.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    97. mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma. Sci Transl Med. 2012 Jun 20; 4(139):139ra84. Thomas HE, Mercer CA, Carnevalli LS, Park J, Andersen JB, Conner EA, Tanaka K, Matsutani T, Iwanami A, Aronow BJ, Manway L, Maira SM, Thorgeirsson SS, Mischel PS, Thomas G, Kozma SC. PMID: 22539746.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimals
    98. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov. 2012 May; 2(5):458-71. Vivanco I, Robins HI, Rohle D, Campos C, Grommes C, Nghiemphu PL, Kubek S, Oldrini B, Chheda MG, Yannuzzi N, Tao H, Zhu S, Iwanami A, Kuga D, Dang J, Pedraza A, Brennan CW, Heguy A, Liau LM, Lieberman F, Yung WK, Gilbert MR, Reardon DA, Drappatz J, Wen PY, Lamborn KR, Chang SM, Prados MD, Fine HA, Horvath S, Wu N, Lassman AB, DeAngelis LM, Yong WH, Kuhn JG, Mischel PS, Mehta MP, Cloughesy TF, Mellinghoff IK. PMID: 22588883.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansAnimalsCells
    99. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways. PLoS One. 2012; 7(3):e33431. Muto J, Imai T, Ogawa D, Nishimoto Y, Okada Y, Mabuchi Y, Kawase T, Iwanami A, Mischel PS, Saya H, Yoshida K, Matsuzaki Y, Okano H. PMID: 22428049.
      View in: PubMed   Mentions: 32     Fields:    Translation:AnimalsCells
    100. Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients. Cancer Chemother Pharmacol. 2012 Jun; 69(6):1507-18. Reardon DA, Conrad CA, Cloughesy T, Prados MD, Friedman HS, Aldape KD, Mischel P, Xia J, DiLea C, Huang J, Mietlowski W, Dugan M, Chen W, Yung WK. PMID: 22392572.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    101. Determining PTEN functional status by network component deduced transcription factor activities. PLoS One. 2012; 7(2):e31053. Tran LM, Chang CJ, Plaisier S, Wu S, Dang J, Mischel PS, Liao JC, Graeber TG, Wu H. PMID: 22347425.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    102. Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases. J Biol Chem. 2012 Feb 24; 287(9):6113-27. Qi Q, He K, Yoo MH, Chan CB, Liu X, Zhang Z, Olson JJ, Xiao G, Wang L, Mao H, Fu H, Tao H, Ramalingam SS, Sun SY, Mischel PS, Ye K. PMID: 22215664.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    103. Will kinase inhibitors make it as glioblastoma drugs? Curr Top Microbiol Immunol. 2012; 355:135-69. Mellinghoff IK, Schultz N, Mischel PS, Cloughesy TF. PMID: 22015553.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    104. Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):419-24. Shi Q, Qin L, Wei W, Geng F, Fan R, Shin YS, Guo D, Hood L, Mischel PS, Heath JR. PMID: 22203961.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    105. Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway. PLoS One. 2011; 6(12):e28973. Atefi M, von Euw E, Attar N, Ng C, Chu C, Guo D, Nazarian R, Chmielowski B, Glaspy JA, Comin-Anduix B, Mischel PS, Lo RS, Ribas A. PMID: 22194965.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    106. Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients. J Clin Invest. 2012 Jan; 122(1):253-66. Agnihotri S, Gajadhar AS, Ternamian C, Gorlia T, Diefes KL, Mischel PS, Kelly J, McGown G, Thorncroft M, Carlson BL, Sarkaria JN, Margison GP, Aldape K, Hawkins C, Hegi M, Guha A. PMID: 22156195.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    107. Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth. Mol Cancer Res. 2012 Jan; 10(1):156-66. Woerner BM, Luo J, Brown KR, Jackson E, Dahiya SM, Mischel P, Benovic JL, Piwnica-Worms D, Rubin JB. PMID: 22086906.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    108. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol. 2011 Dec 01; 29(34):4482-90. Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS. PMID: 22025148.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCells
    109. Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells. Mol Cancer Res. 2011 Dec; 9(12):1668-85. Liu Y, Ye F, Yamada K, Tso JL, Zhang Y, Nguyen DH, Dong Q, Soto H, Choe J, Dembo A, Wheeler H, Eskin A, Schmid I, Yong WH, Mischel PS, Cloughesy TF, Kornblum HI, Nelson SF, Liau LM, Tso CL. PMID: 22013079.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    110. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov. 2011 Oct; 1(5):442-56. Guo D, Reinitz F, Youssef M, Hong C, Nathanson D, Akhavan D, Kuga D, Amzajerdi AN, Soto H, Zhu S, Babic I, Tanaka K, Dang J, Iwanami A, Gini B, Dejesus J, Lisiero DD, Huang TT, Prins RM, Wen PY, Robins HI, Prados MD, Deangelis LM, Mellinghoff IK, Mehta MP, James CD, Chakravarti A, Cloughesy TF, Tontonoz P, Mischel PS. PMID: 22059152.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansAnimalsCells
    111. Oncogenic EGFR signaling activates an mTORC2-NF-?B pathway that promotes chemotherapy resistance. Cancer Discov. 2011 Nov; 1(6):524-38. Tanaka K, Babic I, Nathanson D, Akhavan D, Guo D, Gini B, Dang J, Zhu S, Yang H, De Jesus J, Amzajerdi AN, Zhang Y, Dibble CC, Dan H, Rinkenbaugh A, Yong WH, Vinters HV, Gera JF, Cavenee WK, Cloughesy TF, Manning BD, Baldwin AS, Mischel PS. PMID: 22145100.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    112. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A. 2011 Sep 20; 108(38):16062-7. Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M, Popescu R, Della Donna L, Evers P, Dekmezian C, Reue K, Christofk H, Mischel PS, Pajonk F. PMID: 21900605.
      View in: PubMed   Mentions: 129     Fields:    Translation:HumansCells
    113. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS One. 2011; 6(9):e24217. Jijiwa M, Demir H, Gupta S, Leung C, Joshi K, Orozco N, Huang T, Yildiz VO, Shibahara I, de Jesus JA, Yong WH, Mischel PS, Fernandez S, Kornblum HI, Nakano I. PMID: 21915300.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimalsCells
    114. Activation of Src induces mitochondrial localisation of de2-7EGFR (EGFRvIII) in glioma cells: implications for glucose metabolism. J Cell Sci. 2011 Sep 01; 124(Pt 17):2938-50. Cvrljevic AN, Akhavan D, Wu M, Martinello P, Furnari FB, Johnston AJ, Guo D, Pike L, Cavenee WK, Scott AM, Mischel PS, Hoogenraad NJ, Johns TG. PMID: 21878501.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    115. Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Oct; 13(10):1151-61. Ellingson BM, Cloughesy TF, Lai A, Mischel PS, Nghiemphu PL, Lalezari S, Schmainda KM, Pope WB. PMID: 21856685.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    116. Lost - and found - in translation. J Clin Invest. 2011 Aug; 121(8):3357-9. Mischel PS. PMID: 21804196.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    117. Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2012 Jan; 106(1):111-9. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Lalezari S, Zaw T, Motevalibashinaeini K, Mischel PS, Pope WB. PMID: 21706273.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    118. Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations. J Transl Med. 2011 May 24; 9:76. Niehr F, von Euw E, Attar N, Guo D, Matsunaga D, Sazegar H, Ng C, Glaspy JA, Recio JA, Lo RS, Mischel PS, Comin-Anduix B, Ribas A. PMID: 21609436.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    119. Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway. Neuro Oncol. 2011 Jun; 13(6):622-34. Nakano I, Joshi K, Visnyei K, Hu B, Watanabe M, Lam D, Wexler E, Saigusa K, Nakamura Y, Laks DR, Mischel PS, Viapiano M, Kornblum HI. PMID: 21558073.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    120. A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas. J Exp Med. 2011 Apr 11; 208(4):689-702. Agnihotri S, Wolf A, Munoz DM, Smith CJ, Gajadhar A, Restrepo A, Clarke ID, Fuller GN, Kesari S, Dirks PB, McGlade CJ, Stanford WL, Aldape K, Mischel PS, Hawkins C, Guha A. PMID: 21464220.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    121. Musashi1 cooperates in abnormal cell lineage protein 28 (Lin28)-mediated let-7 family microRNA biogenesis in early neural differentiation. J Biol Chem. 2011 May 06; 286(18):16121-30. Kawahara H, Okada Y, Imai T, Iwanami A, Mischel PS, Okano H. PMID: 21378162.
      View in: PubMed   Mentions: 33     Fields:    Translation:AnimalsCells
    122. Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Apr; 13(4):401-9. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB. PMID: 21324937.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    123. New strategies in the molecular targeting of glioblastoma: how do you hit a moving target? Clin Cancer Res. 2011 Jan 01; 17(1):6-11. Cloughesy TF, Mischel PS. PMID: 21208902.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    124. Charting the course across the blood-brain barrier. J Clin Invest. 2011 Jan; 121(1):31-3. Nathanson D, Mischel PS. PMID: 21183784.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    125. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol. 2011 Jan 10; 29(2):142-8. Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, Kolevska T, Polikoff J, Fehrenbacher L, Elashoff R, Cloughesy T. PMID: 21135282.
      View in: PubMed   Mentions: 176     Fields:    Translation:HumansCTClinical Trials
    126. Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation. Pediatr Blood Cancer. 2010 Oct; 55(4):644-51. Panosyan EH, Laks DR, Masterman-Smith M, Mottahedeh J, Yong WH, Cloughesy TF, Lazareff JA, Mischel PS, Moore TB, Kornblum HI. PMID: 20589659.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    127. A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. Cancer Res. 2010 Aug 01; 70(15):6128-38. Sun J, Masterman-Smith MD, Graham NA, Jiao J, Mottahedeh J, Laks DR, Ohashi M, DeJesus J, Kamei K, Lee KB, Wang H, Yu ZT, Lu YT, Hou S, Li K, Liu M, Zhang N, Wang S, Angenieux B, Panosyan E, Samuels ER, Park J, Williams D, Konkankit V, Nathanson D, van Dam RM, Phelps ME, Wu H, Liau LM, Mischel PS, Lazareff JA, Kornblum HI, Yong WH, Graeber TG, Tseng HR. PMID: 20631065.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    128. Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumab. Pharmgenomics Pers Med. 2010; 3:79-85. Wagle N, Nghiemphu L, Lai A, Pope W, Mischel PS, Cloughesy T. PMID: 23226044.
      View in: PubMed   Mentions:
    129. mTOR signaling in glioblastoma: lessons learned from bench to bedside. Neuro Oncol. 2010 Aug; 12(8):882-9. Akhavan D, Cloughesy TF, Mischel PS. PMID: 20472883.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCells
    130. Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032. J Transl Med. 2010 Apr 20; 8:39. Søndergaard JN, Nazarian R, Wang Q, Guo D, Hsueh T, Mok S, Sazegar H, MacConaill LE, Barretina JG, Kehoe SM, Attar N, von Euw E, Zuckerman JE, Chmielowski B, Comin-Anduix B, Koya RC, Mischel PS, Lo RS, Ribas A. PMID: 20406486.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansAnimalsCells
    131. The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation. Proc Natl Acad Sci U S A. 2010 Apr 06; 107(14):6459-64. Vivanco I, Rohle D, Versele M, Iwanami A, Kuga D, Oldrini B, Tanaka K, Dang J, Kubek S, Palaskas N, Hsueh T, Evans M, Mulholland D, Wolle D, Rajasekaran S, Rajasekaran A, Liau LM, Cloughesy TF, Dikic I, Brennan C, Wu H, Mischel PS, Perera T, Mellinghoff IK. PMID: 20308550.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCells
    132. AMPK: A metabolic checkpoint that regulates the growth of EGFR activated glioblastomas. Cell Cycle. 2010 Jan 15; 9(2):211-2. Guo D, Cloughesy TF, Radu CG, Mischel PS. PMID: 20023392.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    133. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal. 2009 Dec 15; 2(101):ra82. Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H, Lin KY, Huang TT, Akhavan D, Hock MB, Zhu S, Kofman AA, Bensinger SJ, Yong WH, Vinters HV, Horvath S, Watson AD, Kuhn JG, Robins HI, Mehta MP, Wen PY, DeAngelis LM, Prados MD, Mellinghoff IK, Cloughesy TF, Mischel PS. PMID: 20009104.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansCells
    134. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet. 2010 Jan; 42(1):77-82. Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, Mischel PS, Liau L, Cloughesy TF, Mellinghoff IK, Solit DB, Chan TA. PMID: 19946270.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansAnimalsCells
    135. Genomic landscape of meningiomas. Brain Pathol. 2010 Jul; 20(4):751-62. Lee Y, Liu J, Patel S, Cloughesy T, Lai A, Farooqi H, Seligson D, Dong J, Liau L, Becker D, Mischel P, Shams S, Nelson S. PMID: 20015288.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    136. An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. Curr Biol. 2009 Nov 17; 19(21):1788-98. Tarcic G, Boguslavsky SK, Wakim J, Kiuchi T, Liu A, Reinitz F, Nathanson D, Takahashi T, Mischel PS, Ng T, Yarden Y. PMID: 19836242.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    137. PTEN dosage is essential for neurofibroma development and malignant transformation. Proc Natl Acad Sci U S A. 2009 Nov 17; 106(46):19479-84. Gregorian C, Nakashima J, Dry SM, Nghiemphu PL, Smith KB, Ao Y, Dang J, Lawson G, Mellinghoff IK, Mischel PS, Phelps M, Parada LF, Liu X, Sofroniew MV, Eilber FC, Wu H. PMID: 19846776.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimals
    138. A case for a science-informed perspective on health care reform. J Clin Invest. 2009 Oct; 119(10):2855. Mischel P. PMID: 20069712.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    139. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res. 2009 Sep 01; 69(17):6889-98. Lu KV, Zhu S, Cvrljevic A, Huang TT, Sarkaria S, Ahkavan D, Dang J, Dinca EB, Plaisier SB, Oderberg I, Lee Y, Chen Z, Caldwell JS, Xie Y, Loo JA, Seligson D, Chakravari A, Lee FY, Weinmann R, Cloughesy TF, Nelson SF, Bergers G, Graeber T, Furnari FB, James CD, Cavenee WK, Johns TG, Mischel PS. PMID: 19690143.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansAnimalsCells
    140. Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone. J Neurooncol. 2010 Feb; 96(3):359-67. Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM, Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB. PMID: 19655089.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    141. Striking the balance between PTEN and PDK1: it all depends on the cell context. Genes Dev. 2009 Aug 01; 23(15):1699-704. Iwanami A, Cloughesy TF, Mischel PS. PMID: 19651981.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    142. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proc Natl Acad Sci U S A. 2009 Aug 04; 106(31):12932-7. Guo D, Hildebrandt IJ, Prins RM, Soto H, Mazzotta MM, Dang J, Czernin J, Shyy JY, Watson AD, Phelps M, Radu CG, Cloughesy TF, Mischel PS. PMID: 19625624.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansAnimalsCells
    143. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. Cancer Cell. 2009 Jul 07; 16(1):44-54. McGillicuddy LT, Fromm JA, Hollstein PE, Kubek S, Beroukhim R, De Raedt T, Johnson BW, Williams SM, Nghiemphu P, Liau LM, Cloughesy TF, Mischel PS, Parret A, Seiler J, Moldenhauer G, Scheffzek K, Stemmer-Rachamimov AO, Sawyers CL, Brennan C, Messiaen L, Mellinghoff IK, Cichowski K. PMID: 19573811.
      View in: PubMed   Mentions: 64     Fields:    Translation:AnimalsCells
    144. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. Radiology. 2009 Jul; 252(1):182-9. Pope WB, Kim HJ, Huo J, Alger J, Brown MS, Gjertson D, Sai V, Young JR, Tekchandani L, Cloughesy T, Mischel PS, Lai A, Nghiemphu P, Rahmanuddin S, Goldin J. PMID: 19561256.
      View in: PubMed   Mentions: 141     Fields:    Translation:Humans
    145. Targeted therapy for malignant glioma patients: lessons learned and the road ahead. Neurotherapeutics. 2009 Jul; 6(3):500-12. Huang TT, Sarkaria SM, Cloughesy TF, Mischel PS. PMID: 19560740.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    146. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci U S A. 2009 Jun 09; 106(23):9435-40. Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, Solit DB, Paty PB, Rohle D, Vivanco I, Chmielecki J, Pao W, Ladanyi M, Gerald WL, Liau L, Cloughesy TC, Mischel PS, Sander C, Taylor B, Schultz N, Major J, Heguy A, Fang F, Mellinghoff IK, Chan TA. PMID: 19478061.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansCells
    147. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neurooncol. 2009 Aug; 94(1):1-19. Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY, Tso JL, Liu JY, Konkankit V, Cloughesy TF, Mischel PS, Lane TF, Liau LM, Nelson SF, Tso CL. PMID: 19468690.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    148. Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience. Neurology. 2009 Apr 07; 72(14):1217-22. Nghiemphu PL, Liu W, Lee Y, Than T, Graham C, Lai A, Green RM, Pope WB, Liau LM, Mischel PS, Nelson SF, Elashoff R, Cloughesy TF. PMID: 19349600.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    149. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells. 2009 Apr; 27(4):980-7. Laks DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, Yong WH, Vinters HV, Liau LM, Lazareff JA, Mischel PS, Cloughesy TF, Horvath S, Kornblum HI. PMID: 19353526.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansAnimalsCells
    150. Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinib. Cancer Res. 2009 Apr 01; 69(7):3173-9. Dumont RA, Hildebrandt I, Su H, Haubner R, Reischl G, Czernin JG, Mischel PS, Weber WA. PMID: 19318569.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    151. A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM). J Neurooncol. 2009 Mar; 92(1):99-105. Kreisl TN, Lassman AB, Mischel PS, Rosen N, Scher HI, Teruya-Feldstein J, Shaffer D, Lis E, Abrey LE. PMID: 19018475.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCTClinical Trials
    152. Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. J Clin Oncol. 2008 Dec 01; 26(34):5603-9. Brown PD, Krishnan S, Sarkaria JN, Wu W, Jaeckle KA, Uhm JH, Geoffroy FJ, Arusell R, Kitange G, Jenkins RB, Kugler JW, Morton RF, Rowland KM, Mischel P, Yong WH, Scheithauer BW, Schiff D, Giannini C, Buckner JC. PMID: 18955445.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCTClinical Trials
    153. Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age. BMC Med Genomics. 2008 Oct 21; 1:52. Lee Y, Scheck AC, Cloughesy TF, Lai A, Dong J, Farooqi HK, Liau LM, Horvath S, Mischel PS, Nelson SF. PMID: 18940004.
      View in: PubMed   Mentions: 84     Fields:    
    154. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. Radiology. 2008 Oct; 249(1):268-77. Pope WB, Chen JH, Dong J, Carlson MR, Perlina A, Cloughesy TF, Liau LM, Mischel PS, Nghiemphu P, Lai A, Nelson SF. PMID: 18796682.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    155. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci. 2008 Jun 04; 28(23):5870-8. de la Iglesia N, Konopka G, Lim KL, Nutt CL, Bromberg JF, Frank DA, Mischel PS, Louis DN, Bonni A. PMID: 18524891.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    156. Evidence for a potential tumor suppressor role for the Na,K-ATPase beta1-subunit. Histol Histopathol. 2008 04; 23(4):459-67. Inge LJ, Rajasekaran SA, Yoshimoto K, Mischel PS, McBride W, Landaw E, Rajasekaran AK. PMID: 18228203.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    157. Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability. Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1372-80. Lai A, Filka E, McGibbon B, Nghiemphu PL, Graham C, Yong WH, Mischel P, Liau LM, Bergsneider M, Pope W, Selch M, Cloughesy T. PMID: 18355978.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCTClinical Trials
    158. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol. 2008 Feb 15; 180(4):2214-24. Jindra PT, Hsueh A, Hong L, Gjertson D, Shen XD, Gao F, Dang J, Mischel PS, Baldwin WM, Fishbein MC, Kupiec-Weglinski JW, Reed EF. PMID: 18250428.
      View in: PubMed   Mentions: 49     Fields:    Translation:AnimalsCells
    159. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med. 2008 Jan 22; 5(1):e8. Cloughesy TF, Yoshimoto K, Nghiemphu P, Brown K, Dang J, Zhu S, Hsueh T, Chen Y, Wang W, Youngkin D, Liau L, Martin N, Becker D, Bergsneider M, Lai A, Green R, Oglesby T, Koleto M, Trent J, Horvath S, Mischel PS, Mellinghoff IK, Sawyers CL. PMID: 18215105.
      View in: PubMed   Mentions: 238     Fields:    Translation:HumansCellsCTClinical Trials
    160. Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples. Clin Cancer Res. 2008 Jan 15; 14(2):488-93. Yoshimoto K, Dang J, Zhu S, Nathanson D, Huang T, Dumont R, Seligson DB, Yong WH, Xiong Z, Rao N, Winther H, Chakravarti A, Bigner DD, Mellinghoff IK, Horvath S, Cavenee WK, Cloughesy TF, Mischel PS. PMID: 18223223.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    161. Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J Neurosci Res. 2008 Jan; 86(1):48-60. Nakano I, Masterman-Smith M, Saigusa K, Paucar AA, Horvath S, Shoemaker L, Watanabe M, Negro A, Bajpai R, Howes A, Lelievre V, Waschek JA, Lazareff JA, Freije WA, Liau LM, Gilbertson RJ, Cloughesy TF, Geschwind DH, Nelson SF, Mischel PS, Terskikh AV, Kornblum HI. PMID: 17722061.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansAnimalsCells
    162. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A. 2007 Dec 11; 104(50):20007-12. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, Perner S, Prensner J, Debiasi RM, Demichelis F, Hatton C, Rubin MA, Garraway LA, Nelson SF, Liau L, Mischel PS, Cloughesy TF, Meyerson M, Golub TA, Lander ES, Mellinghoff IK, Sellers WR. PMID: 18077431.
      View in: PubMed   Mentions: 455     Fields:    Translation:HumansCells
    163. Lymphomatosis cerebri presenting as rapidly progressive dementia. Neurologist. 2007 May; 13(3):150-3. Weaver JD, Vinters HV, Koretz B, Xiong Z, Mischel P, Kado D. PMID: 17495760.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    164. Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2. Clin Cancer Res. 2007 May 01; 13(9):2592-8. Carlson MR, Pope WB, Horvath S, Braunstein JG, Nghiemphu P, Tso CL, Mellinghoff I, Lai A, Liau LM, Mischel PS, Dong J, Nelson SF, Cloughesy TF. PMID: 17473188.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    165. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007 Mar; 39(3):347-51. Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Macconnaill LE, Lee JC, Nicoletti R, Hatton C, Goyette M, Girard L, Majmudar K, Ziaugra L, Wong KK, Gabriel S, Beroukhim R, Peyton M, Barretina J, Dutt A, Emery C, Greulich H, Shah K, Sasaki H, Gazdar A, Minna J, Armstrong SA, Mellinghoff IK, Hodi FS, Dranoff G, Mischel PS, Cloughesy TF, Nelson SF, Liau LM, Mertz K, Rubin MA, Moch H, Loda M, Catalona W, Fletcher J, Signoretti S, Kaye F, Anderson KC, Demetri GD, Dummer R, Wagner S, Herlyn M, Sellers WR, Meyerson M, Garraway LA. PMID: 17293865.
      View in: PubMed   Mentions: 424     Fields:    Translation:Humans
    166. PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):378-81. Mellinghoff IK, Cloughesy TF, Mischel PS. PMID: 17255257.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    167. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med. 2007 Jan; 13(1):84-8. Parsa AT, Waldron JS, Panner A, Crane CA, Parney IF, Barry JJ, Cachola KE, Murray JC, Tihan T, Jensen MC, Mischel PS, Stokoe D, Pieper RO. PMID: 17159987.
      View in: PubMed   Mentions: 416     Fields:    Translation:HumansCells
    168. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med. 2006 Dec; 3(12):e485. Lee JC, Vivanco I, Beroukhim R, Huang JH, Feng WL, DeBiasi RM, Yoshimoto K, King JC, Nghiemphu P, Yuza Y, Xu Q, Greulich H, Thomas RK, Paez JG, Peck TC, Linhart DJ, Glatt KA, Getz G, Onofrio R, Ziaugra L, Levine RL, Gabriel S, Kawaguchi T, O'Neill K, Khan H, Liau LM, Nelson SF, Rao PN, Mischel P, Pieper RO, Cloughesy T, Leahy DJ, Sellers WR, Sawyers CL, Meyerson M, Mellinghoff IK. PMID: 17177598.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansAnimalsCells
    169. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A. 2006 Nov 14; 103(46):17402-7. Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, Lee Y, Scheck AC, Liau LM, Wu H, Geschwind DH, Febbo PG, Kornblum HI, Cloughesy TF, Nelson SF, Mischel PS. PMID: 17090670.
      View in: PubMed   Mentions: 238     Fields:    Translation:HumansAnimalsCells
    170. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res. 2006 Sep; 4(9):607-19. Tso CL, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, Cloughesy TF, Liau LM, Nelson SF. PMID: 16966431.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    171. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. Cancer Res. 2006 Aug 15; 66(16):7864-9. Wang MY, Lu KV, Zhu S, Dia EQ, Vivanco I, Shackleford GM, Cavenee WK, Mellinghoff IK, Cloughesy TF, Sawyers CL, Mischel PS. PMID: 16912159.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    172. HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway. Cancer Res. 2006 Jul 01; 66(13):6756-62. Wang CC, Liao YP, Mischel PS, Iwamoto KS, Cacalano NA, McBride WH. PMID: 16818651.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    173. Using molecular information to guide brain tumor therapy. Nat Clin Pract Neurol. 2006 May; 2(5):232-3. Mischel PS, Cloughesy T. PMID: 16932555.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    174. MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology. 2006 Apr 25; 66(8):1258-60. Pope WB, Lai A, Nghiemphu P, Mischel P, Cloughesy TF. PMID: 16636248.
      View in: PubMed   Mentions: 110     Fields:    Translation:Humans
    175. Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks. BMC Genomics. 2006 Mar 03; 7:40. Carlson MR, Zhang B, Fang Z, Mischel PS, Horvath S, Nelson SF. PMID: 16515682.
      View in: PubMed   Mentions: 127     Fields:    Translation:AnimalsCells
    176. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res. 2006 Jan 01; 66(1):159-67. Tso CL, Freije WA, Day A, Chen Z, Merriman B, Perlina A, Lee Y, Dia EQ, Yoshimoto K, Mischel PS, Liau LM, Cloughesy TF, Nelson SF. PMID: 16397228.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    177. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med. 2005 Nov 10; 353(19):2012-24. Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, Beroukhim R, Peck TC, Lee JC, Sellers WR, Stokoe D, Prados M, Cloughesy TF, Sawyers CL, Mischel PS. PMID: 16282176.
      View in: PubMed   Mentions: 499     Fields:    Translation:HumansCells
    178. MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol. 2005 Nov-Dec; 26(10):2466-74. Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF. PMID: 16286386.
      View in: PubMed   Mentions: 119     Fields:    Translation:Humans
    179. Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res. 2005 Aug 01; 11(15):5515-25. Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD. PMID: 16061868.
      View in: PubMed   Mentions: 181     Fields:    Translation:HumansCellsCTClinical Trials
    180. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. J Nucl Med. 2005 Jun; 46(6):945-52. Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, Silverman DH. PMID: 15937304.
      View in: PubMed   Mentions: 137     Fields:    Translation:Humans
    181. Robustness of gene expression profiling in glioma specimen samplings and derived cell lines. Brain Res Mol Brain Res. 2005 May 20; 136(1-2):99-103. Mehrian Shai R, Reichardt JK, Ya-Hsuan H, Kremen TJ, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. PMID: 15893592.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    182. Differential induction of glioblastoma migration and growth by two forms of pleiotrophin. J Biol Chem. 2005 Jul 22; 280(29):26953-64. Lu KV, Jong KA, Kim GY, Singh J, Dia EQ, Yoshimoto K, Wang MY, Cloughesy TF, Nelson SF, Mischel PS. PMID: 15908427.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    183. New roles for galectins in brain tumors--from prognostic markers to therapeutic targets. Brain Pathol. 2005 Apr; 15(2):124-32. Stillman BN, Mischel PS, Baum LG. PMID: 15912884.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    184. DNA-microarray analysis of brain cancer: molecular classification for therapy. Nat Rev Neurosci. 2004 Oct; 5(10):782-92. Mischel PS, Cloughesy TF, Nelson SF. PMID: 15378038.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimals
    185. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004 Sep 15; 64(18):6503-10. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF. PMID: 15374961.
      View in: PubMed   Mentions: 253     Fields:    Translation:Humans
    186. p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition. Oncogene. 2004 Feb 12; 23(6):1283-90. Wang Y, Zhu S, Cloughesy TF, Liau LM, Mischel PS. PMID: 14961077.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    187. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lab Invest. 2004 Jan; 84(1):8-20. Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS. PMID: 14631378.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    188. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene. 2003 Jul 31; 22(31):4918-23. Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. PMID: 12894235.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    189. Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res. 2003 Jun 01; 63(11):2742-6. Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL, Mischel PS. PMID: 12782577.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCells
    190. Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy. Cancer Biol Ther. 2003 May-Jun; 2(3):242-7. Mischel PS, Nelson SF, Cloughesy TF. PMID: 12878856.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    191. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene. 2003 Apr 17; 22(15):2361-73. Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF, Nelson SF. PMID: 12700671.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    192. Targeted molecular therapy of GBM. Brain Pathol. 2003 Jan; 13(1):52-61. Mischel PS, Cloughesy TF. PMID: 12580545.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCells
    193. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res. 2002 Sep; 8(9):2894-901. Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS. PMID: 12231534.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    194. Nerve growth factor signals via preexisting TrkA receptor oligomers. Biophys J. 2002 Aug; 83(2):968-76. Mischel PS, Umbach JA, Eskandari S, Smith SG, Gundersen CB, Zampighi GA. PMID: 12124278.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    195. Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B. J Neuropathol Exp Neurol. 2001 Jul; 60(7):711-23. Catania MG, Mischel PS, Vinters HV. PMID: 11444800.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    196. The extracellular domain of p75NTR is necessary to inhibit neurotrophin-3 signaling through TrkA. J Biol Chem. 2001 Apr 06; 276(14):11294-301. Mischel PS, Smith SG, Vining ER, Valletta JS, Mobley WC, Reichardt LF. PMID: 11150291.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    197. Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report. Neurosurg Focus. 2000 Dec 15; 9(6):e8. Liau LM, Black KL, Martin NA, Sykes SN, Bronstein JM, Jouben-Steele L, Mischel PS, Belldegrun A, Cloughesy TF. PMID: 16817691.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    198. Cortical dysplasia, genetic abnormalities and neurocutaneous syndromes. Dev Neurosci. 1999 Nov; 21(3-5):248-59. Vinters HV, Park SH, Johnson MW, Mischel PS, Catania M, Kerfoot C. PMID: 10575248.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    199. Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disord. 1999 Mar-Apr; 10(2):152-7. Bakshi R, Mazziotta JC, Mischel PS, Jahan R, Seligson DB, Vinters HV. PMID: 10026390.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    200. Bilateral neuropathologic changes in a child with hemimegalencephaly. Pediatr Neurol. 1997 Nov; 17(4):344-9. Jahan R, Mischel PS, Curran JG, Peacock WJ, Shields DW, Vinters HV. PMID: 9436800.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    201. Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues. Mod Pathol. 1996 Nov; 9(11):1071-80. Menchine M, Emelin JK, Mischel PS, Haag TA, Norman MG, Pepkowitz SH, Welsh CT, Townsend JJ, Vinters HV. PMID: 8933518.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    202. Arteriovenous malformation animal model for radiosurgery: the rete mirabile. AJNR Am J Neuroradiol. 1996 Sep; 17(8):1451-8. De Salles AA, Solberg TD, Mischel P, Massoud TF, Plasencia A, Goetsch S, De Souza E, Viñuela F. PMID: 8883640.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    203. Childhood generalized and mesial temporal epilepsies demonstrate different amounts and patterns of hippocampal neuron loss and mossy fibre synaptic reorganization. Brain. 1996 Jun; 119 ( Pt 3):965-87. Mathern GW, Babb TL, Mischel PS, Vinters HV, Pretorius JK, Leite JP, Peacock WJ. PMID: 8673505.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    204. Central nervous system. Pathology (Phila). 1996; 3(2):513-34. Vinters HV, Mischel PS, Ranchod M. PMID: 8795833.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    205. Hyperacute thermal lesions: MR imaging evaluation of development in the brain. Radiology. 1995 Aug; 196(2):517-20. Farahani K, Mischel PS, Black KL, De Salles AA, Anzai Y, Lufkin RB. PMID: 7617870.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    206. Neuropathology. Neurosurg Clin N Am. 1995 Jul; 6(3):565-79. Mischel PS, Vinters HV. PMID: 7670329.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    207. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol. 1995 Mar; 54(2):137-53. Mischel PS, Nguyen LP, Vinters HV. PMID: 7876884.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    208. Sneddon's syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence. Neurology. 1995 Mar; 45(3 Pt 1):557-60. Geschwind DH, FitzPatrick M, Mischel PS, Cummings JL. PMID: 7898716.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    209. Coccidioidomycosis of the central nervous system: neuropathological and vasculopathic manifestations and clinical correlates. Clin Infect Dis. 1995 Feb; 20(2):400-5. Mischel PS, Vinters HV. PMID: 7742448.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    210. Creutzfeldt-Jakob disease with mixed transcortical aphasia: insights into echolalia. Behav Neurol. 1994; 7(3):197-203. McPherson SE, Kuratani JD, Cummings JL, Shih J, Mischel PS, Vinters HV. PMID: 24487337.
      View in: PubMed   Mentions: 2     Fields:    
    Paul's Networks
    Concepts (773)
    Derived automatically from this person's publications.
    _
    Co-Authors (109)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _